Name	Info	Provider	Link
COVID-19 (Coronavirus Disease 2019)	free resource	MedlinePlus Health Information	https://medlineplus.gov/covid19coronavirusdisease2019.html
	subscription/membership/fee required	Ovid Technologies, Inc.	http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linkout&SEARCH=33704352.ui
	free resource	PubMed Central	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33704352/
	free resource	Europe PubMed Central	https://europepmc.org/abstract/MED/33704352
	free resource	NCI CPTC Antibody Characterization Program	https://antibodies.cancer.gov/detail/CPTC-CD4-2
	free resource	NCI CPTAC Assay Portal	https://assays.cancer.gov/CPTAC-438
	free resource	ImmPort - Shared Data - Datasets	https://www.immport.org/shared/search?text=33704352
Cited by Patents in	free resource	The Lens - Patent Citations	https://www.lens.org/lens/search/patent/list?q=citation_id:33704352
	free resource	scite Smart Citations	https://scite.ai/reports/33704352
	subscription/membership/fee required	Silverchair Information Systems	https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.3645
A Randomized, Double-blind, Placebo-controlled Phase 1/2a Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Ad26COVS1 in Adults Aged 18 to 55 Years Inclusive and Adults Aged 65 Years and Older	free resource	The YODA Project	https://yoda.yale.edu/clinical-trial/nct04436276-a-randomized-double-blind-placebo-controlled-phase-1-2a-study-to-evaluate-the-safety-reactogenicity-and-immunogenicity-of-ad26covs1-in-adults-aged-18-to-55-years-inclusive-and/